This resolution supports designating April 11-17, 2026, as "Black Maternal Health Week." The designation aims to bring national attention to the maternal and reproductive health crisis in the United States, specifically emphasizing the importance of reducing maternal mortality and morbidity among Black women and birthing people.
The KIDNEY Remote Monitoring Act (H.R. 8319) aims to ensure Medicare payment for remote physiologic monitoring services provided to individuals with end-stage renal disease (ESRD) who receive home dialysis. The bill amends the Social Security Act to direct that these monitoring services, when furnished by a physician, will be paid for under Medicare Part B. This change would take effect for services provided on or after January 1, 2028, aligning their payment with the standard fee schedule for physician services.
The Carlton H. Ingram Veterans’ Benefits Improvement Act amends federal law to change how the Department of Veterans Affairs (VA) rates disabilities for veterans. The bill requires the VA's disability rating schedule to discount the beneficial effects of medication or treatment when assessing a veteran's condition, if a baseline without those effects can be established. This means the VA should rate the underlying severity of a service-connected disability, rather than its improved state due to ongoing treatment. However, the bill clarifies that this change does not prevent veterans from seeking compensation for additional disabilities caused by their medication or treatment, or for the aggravation of a pre-existing service-connected condition.
The "Funding Early Childhood is the Right IDEA Act" proposes to increase authorized funding for specific programs under the Individuals with Disabilities Education Act (IDEA). This bill sets new appropriation levels for Part C of IDEA, which provides early intervention services for infants and toddlers with disabilities and their families. It also increases authorized funding for Section 619 of IDEA, which supports preschool special education for children aged three to five. These funding authorizations are scheduled for fiscal years 2027 through 2031, directly affecting children with disabilities and the state and local agencies that provide these services.
This bill enhances the Food and Drug Administration's (FDA) authority and resources concerning human foods, directly affecting food manufacturers, researchers, and consumers. It establishes a permanent Advisory Committee on Human Foods and a center of excellence for nutrition science, while also creating a grant program for critical research areas like infant nutrition and ultra-processed foods. The bill requires processed food manufacturers (excluding farms and restaurants) to provide the FDA access to recipe records and submit non-labeled ingredients, which the FDA must then publish online. Additionally, it directs the FDA to form a public-private partnership to address chemical limits in foods and exempts voluntary FDA research from certain paperwork reduction requirements.
The Educational Equity Challenge Grant Act of 2026 establishes a federal grant program to help eligible educational entities address students' academic, social-emotional, mental, behavioral, and physical health needs, including those impacted by the COVID-19 pandemic. Administered by the Secretary of Education, the program awards funds for either implementing proven, evidence-based strategies or designing and evaluating new, educator-initiated proposals. Priority for these grants is given to entities serving high-need student populations, such as those in rural areas, low-income communities, and various disproportionately affected groups. Recipients must report annually on how funds were used and their impact on student outcomes.
The Cardiovascular Disease Early Detection and Prevention Act of 2026 mandates that private health insurance plans, Medicare, and Medicaid cover specific cardiovascular disease screenings. The bill requires coverage for testing of lipoprotein(a) (Lp(a)) and apolipoprotein B (ApoB) levels. This coverage applies to individuals with a family history of premature cardiovascular disease, a personal history of heart attack or stroke, elevated LDL cholesterol, diabetes, obesity, or other recognized cardiovascular risk factors. For eligible individuals, these tests must be provided without any cost sharing, such as co-pays or deductibles.
This bill, titled the Safeguarding Women from Chemical Abortion Act, aims to revoke federal approval for the drug mifepristone (also known as RU-486) for use in terminating pregnancies. If enacted, the Food and Drug Administration's approval for mifepristone for this indication would be withdrawn within 14 days, making its introduction into interstate commerce for pregnancy termination a violation of federal law. Additionally, the bill establishes a new federal right for individuals to sue manufacturers of mifepristone if they experience bodily injury or harm to mental health attributed to its use for pregnancy termination. This legislation directly affects drug manufacturers, distributors, healthcare providers, and individuals seeking or having used medication abortion.
The Baby Food Safety Act of 2026 aims to enhance the safety of infant and toddler food by regulating contaminants, directly affecting food manufacturers and processors, and ultimately protecting young consumers. The bill requires the Food and Drug Administration (FDA) to establish mandatory limits for toxic elements like lead, cadmium, mercury, and arsenic in infant and toddler food, as well as fruit and vegetable purees and juices. Manufacturers of these foods will be required to implement control programs, conduct regular testing of their final products for these contaminants using accredited laboratories, and maintain detailed records. Food found to exceed established limits or produced by non-compliant facilities will be deemed adulterated, allowing the FDA to enforce these standards, including through mandatory recalls. The bill also grants the FDA expanded authority for remote record inspections and enhances food traceability requirements.
HRES 1207 is a House Resolution that expresses support for protecting Americans from the perceived harmful effects of private equity firms, particularly in essential sectors like housing, child care, healthcare, energy, and nursing homes. The resolution recognizes the need for a comprehensive plan to address these issues. This plan includes raising staffing, safety, and pay standards in care industries, ending taxpayer subsidies for institutional investors buying homes, and guaranteeing legal counsel for tenants. It also calls for greater transparency of private equity ownership, strengthened antitrust reviews, and support for alternative, non-private equity providers in these critical sectors.